Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperine for Oropharyngeal Dysphagia
NCT01383694Phase 2Completed
- Sponsor
- Hospital de Mataró
- Start
- Jun 2011
- Primary completion
- Feb 2012
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of piperine in oropharyngeal dysphagia (2 arms), sponsored by Hospital de Mataró. Primary endpoint: Safety of swallow at 15 months. Started Jun 2011; status: completed.
02
Drugs
piperine
03
Conditions
oropharyngeal dysphagia
Beyond the preview
Go deeper on NCT01383694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01383694.